1 Min Read
Rentschler Biopharma, a contract development and manufacturing organisation (CDMO) specialising in biopharmaceutical products, has announced the appointment of Uwe Buecheler as interim CEO following the stepping down of current CEO Benedikt von Braunmuehl. Buecheler, who is currently Vice Chairman of the Supervisory Board, will take on the role of interim CEO pending the appointment of […] The post Rentschler Biopharma appoints Uwe Buecheler as interim CEO appeared first on Pharmafile.
Work & Theory on January 27, 2026
Uncategorized